|
Sign In to gain access to subscriptions and/or personal tools.
|
Structured care with atorvastatin in patients with type 2 diabetes mellitus and coronary heart diseaseCardiovascular morbidity and mortality in diabetic patients in the GREek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study
Haralampos J Milionis
Department of Internal Medicine, Medical School, University of Ioannina, 451 10, Greece
Vasilios G Athyros
Atherosclerosis Unit, 2nd Propedeutic Department of Internal Medicine, Aristotelian University, Hippocration Hospital, Thessaloniki, 546 42, Greece
Moses Elisaf
Department of Internal Medicine, Medical School, University of Ioannina, 451 10, Greece
Dimitri P Mikhailidis
Department of Clinical Biochemistry, Royal Free Hospital, Royal Free and University College Medical School, London NW3 2QG, UK, MIKHAILIDIS{at}aol.com
The Greace Study Collaborative Group
Key Words: atorvastatin coronary heart disease diabetes mellitus renal function uric acid.
References
- Athyros VG, Papageorgiou AA, Mercouris BR et al. Treatment with atorvastatin to the National Cholesterol Educational Program goals versus usual care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study . Curr Med Res Opin 2002;4:220-8.
- Athyros VG, Papageorgiou AA, Symeonidis AN et al. Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study . Angiology 2003;54:679-90.[Web of Science][Medline]
[Order article via Infotrieve]
- Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) . JAMA 2001;285:2486-97.[Free Full Text]
- Milionis HJ, Elisaf MS Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: Case histories . Curr Med Res Opin 2000;16:164-70.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Fried LF, Orchard TJ, Kasiske BL, for the Lipids and Renal Disease Progression Meta-Analysis Study Group. Effect of lipid reduction on the progression of renal disease: A meta-analysis . Kidney Int 2001;59:260-5.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial . Lancet 2003;361:2005-16.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Athyros VG, Mikhailidis DP, Papageorgiou AA et al. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study . J Clin Pathol 2004;(in press).
- Athyros VG, Elisaf M., Papageorgiou AA et al. The effect of statins versus untreated dyslipidaemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study . Am J Kidney Dis 2004;(in press).
- Papadakis JA, Milionis HJ, Press M., Mikhailidis DP Treating dyslipidaemia in non-insulin dependent diabetes mellitus (NIDDM) - a special reference to statins . J Diabetes Complicat 2001;15:211-26.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Youssef F., Seifalian AM, Jagroop IA et al. The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT) . Eur J Vasc Endovasc Surg 2002;23:358-64.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Youssef F., Gupta P., Seifalian AM et al. The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease . Angiology 2004;55:53-62.[Web of Science][Medline]
[Order article via Infotrieve]
- Kakafika A., Liamis G., Elisaf M., Mikhailidis D. Effect of atorvastatin on serum creatinine levels . Curr Med Res Opin 2001;17:230-1.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Athyros VG, Papageorgiou AA, Elisaf M. et al. Statins and renal function in patients with diabetes mellitus . Curr Med Res Opin 2003;19:615-17.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Dahlof B., Devereux RB, Kjeldsen SE et al; The LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol . Lancet 2002;359:995-1003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hoieggen A., Alderman MH, Kjeldsen SE et al. LIFE Study Group. The impact of serum uric acid on cardiovascular outcomes in the LIFE study . Kidney Int 2004;65:1041-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Daskalopoulou SS, Athyros VG, Elisaf M., Mikhailidis DP Uric acid levels and vascular disease . Curr Med Res Opin 2004;(in press).
The British Journal of Diabetes & Vascular Disease, Vol. 4, No. 2,
94-97 (2004)
DOI: 10.1177/14746514040040020501

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|